Results 201 to 210 of about 4,080,009 (401)
RCT — RIP, or, Can the Pharmaceutical Industry Survive the Genomic Revolution? [PDF]
Robert Dingwall, Paul Martin
openalex +1 more source
R&D Portfolios and Pharmaceutical Licensing [PDF]
We examine how R&D portfolios of drug pipelines affect pharmaceutical licensing, controlling firm size, diversity, and competitors in R&D and product markets.
Junichi Nishimura, Yosuke Okada
core
Controlling the polycrystallinity of CuO nanorods enables directional reconstruction into rod‐like structures that stabilize Cu(OH)2 and increase Cu+ ratios, while modulating interfacial water dynamics to enhance C─C coupling and boost C2+ product formation in CO2 electroreduction.
Hyeon‐Seok Bang +15 more
wiley +1 more source
NHS laboratories can provide a service to the pharmaceutical industry: a personal experience [PDF]
Edward Love +3 more
openalex +1 more source
A π‐bridge engineering strategy enhances intramolecular charge transfer, enabling non‐fullerene acceptors to extend near‐infrared absorption beyond 1200 nm. The resulting organic photodiodes exhibit high detectivity and fast response. These high‐performance devices demonstrate practical potential in photoplethysmography and optical wireless ...
Meng Qiang Li +7 more
wiley +1 more source
Evaluation of Corporate Social Responsibility Practices in the Turkish Pharmaceutical Industry. [PDF]
Azak Sungur S +2 more
europepmc +1 more source
Principles of Process Research and Chemical Development in the Pharmaceutical Industry. Edited by David J. Ager. Marcel Dekker, Inc., New York. 1999. x + 382 pp. 16 × 24 cm. ISBN 0-8247-1058-4. $165.00. [PDF]
Pat N. Confalone
openalex +1 more source
A rationally engineered bifunctional photocatalyst is reported, which achieves simultaneous selective oxidation of biomass‐derived 5‐hydroxymethylfurfural (HMF) to 2,5‐diformylfuran (DFF) and efficient H2 evolution. By precisely positioning Au and Co3O4 on Zn3In2S6 nanosheet, dual interfacial electric fields are well constructed to spatially separate ...
Shiqing Li +8 more
wiley +1 more source
The NHS and the pharmaceutical industry: High risk of harmful interactions. [PDF]
McCartney M.
europepmc +1 more source

